Cargando…

Stage II/III Rectal Cancer Post-Treatment Surveillance Patterns of Care: A SEER- Medicare Study

INTRODUCTION: Despite high rectal cancer recurrence rates, knowledge on post-treatment surveillance utilization is limited. Hence, this study aims to estimate patterns of post-treatment surveillance and determine associated factors. PATIENTS AND METHODS: Retrospective study of 1,024 SEER-Medicare pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chioreso, Catherine, Schroeder, Mary C, Rupp, Irena Gribovskaja, Ammann, Eric, Carter, Knute D, Lynch, Charles F, Chrischilles, Elizabeth A, Charlton, Mary E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457021/ https://www.ncbi.nlm.nih.gov/pubmed/37636523 http://dx.doi.org/10.19080/argh.2021.17.555972

Ejemplares similares

Incidence and Survival Among Young Women With Stage I–III Breast Cancer: SEER 2000–2015
por: Thomas, Alexandra, et al.
Publicado: (2019)

Associations between initiating antihypertensive regimens on stage I–III colorectal cancer outcomes: A Medicare SEER cohort analysis
por: Balkrishnan, Rajesh, et al.
Publicado: (2021)

Comparison of SEER Treatment Data With Medicare Claims
por: Noone, Anne-Michelle, et al.
Publicado: (2016)

Autonomic Nerve Regulation of Colonic Peristalsis in Guinea Pigs
por: Gribovskaja-Rupp, Irena, et al.
Publicado: (2014)

Trends in Sociodemographic Disparities in Colorectal Cancer Staging and Survival: A SEER–Medicare Analysis
por: Liang, Peter S., et al.
Publicado: (2020)

Cardiac Adverse Events Associated With Chemo‐Radiation Versus Chemotherapy for Resectable Stage III Non‐Small‐Cell Lung Cancer: A Surveillance, Epidemiology and End Results‐Medicare Study
por: Herbach, Emma, et al.
Publicado: (2022)

Liver transplantation for non-resectable colorectal liver metastases
por: Aziz, Hassan, et al.
Publicado: (2023)

Treatment Patterns for Patients With Unresected Stage III NSCLC: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database
por: Shang, Shijie, et al.
Publicado: (2022)

Hemochromatosis, Iron Overload–Related Diseases, and Pancreatic Cancer Risk in the Surveillance, Epidemiology, and End Results (SEER)-Medicare
por: Julián-Serrano, Sachelly, et al.
Publicado: (2021)

Overview of the SEER—Medicare Health Outcomes Survey Linked Dataset
por: Ambs, Anita, et al.
Publicado: (2008)

Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)–Medicare investigation of treatment patterns and overall survival
por: Beebe-Dimmer, Jennifer L, et al.
Publicado: (2016)

Hepatocellular Carcinoma Survival by Etiology: A SEER‐Medicare Database Analysis
por: Brar, Gagandeep, et al.
Publicado: (2020)

Opportunities for Personalizing Colorectal Cancer Care: An Analysis of SEER-Medicare Data
por: Rivers, Zachary T., et al.
Publicado: (2022)

Hospital Rurality and Gene Expression Profiling for Early-Stage Breast Cancer among Iowa Residents (2010–2018)
por: Riley, Danielle, et al.
Publicado: (2022)

Regional Difference in Colonic Motility Response to Electrical Field Stimulation in Guinea Pig
por: Kwak, Jung Myun, et al.
Publicado: (2013)

Health-care access dimensions and ovarian cancer survival: SEER-Medicare analysis of the ORCHiD study
por: Montes de Oca, Mary Katherine, et al.
Publicado: (2023)

Severity of comorbid conditions and early-stage breast cancer therapy: linked SEER-medicare data from 1993 to 2005
por: Yasmeen, Shagufta, et al.
Publicado: (2013)

Racial Disparities in Breast Cancer Treatments and Adverse Events in the SEER-Medicare Data
por: Wieder, Robert, et al.
Publicado: (2023)

Post-treatment surveillance testing of patients with colorectal cancer and the association with survival: protocol for a retrospective cohort study of the Surveillance, Epidemiology, and End Results (SEER)-Medicare database
por: Hines, Robert B, et al.
Publicado: (2018)

Photodynamic therapy for stage I and II non-small cell lung cancer: A SEER-Medicare analysis 2000-2016
por: Chhatre, Sumedha, et al.
Publicado: (2022)

Radiation therapy improves survival in rectal small cell cancer - Analysis of Surveillance Epidemiology and End Results (SEER) data
por: Modrek, Aram S, et al.
Publicado: (2015)

Measurement of skeletal related events in SEER-Medicare: a comparison of claims-based methods
por: Aly, Abdalla, et al.
Publicado: (2015)

Examining the relationship between metformin dose and cancer survival: A SEER-Medicare analysis
por: Scarton, Lisa, et al.
Publicado: (2022)

Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis
por: Karim, Mohammad A., et al.
Publicado: (2023)

Adjuvant treatment for the elderly patient with resected gallbladder cancer: a SEER-Medicare analysis
por: de Savornin Lohman, Elise, et al.
Publicado: (2022)

Rural–urban differences in secular trends of locoregional treatment for ductal carcinoma in situ: A patterns of care analysis
por: Riley, Danielle, et al.
Publicado: (2022)

Treatment practice in the elderly patient with chronic lymphocytic leukemia—analysis of the combined SEER and Medicare database
por: Satram-Hoang, Sacha, et al.
Publicado: (2014)

Using Pointwise Mutual Information for Breast Cancer Health Disparities Research With SEER-Medicare Claims
por: Egleston, Brian L., et al.
Publicado: (2023)

The survival and clinicopathological differences between patients with stage IIIA and stage II rectal cancer: An analysis of 12,036 patients in the SEER database
por: Huang, Ben, et al.
Publicado: (2016)

Estimating Medicare Advantage Lock-In Provisions Impact on Vulnerable Medicare Beneficiaries
por: Laschober, Mary
Publicado: (2005)

Differences in Survival between Colon and Rectal Cancer from SEER Data
por: Lee, Yen-Chien, et al.
Publicado: (2013)

The role of adjuvant chemotherapy in stage I–III male breast cancer: a SEER-based analysis
por: Li, Wei-Ping, et al.
Publicado: (2020)

Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER‐medicare analysis
por: Ailawadhi, Sikander, et al.
Publicado: (2017)

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare
por: Petrick, Jessica L., et al.
Publicado: (2017)

SUN-626 Survival of Patients with Gastroenteropancreatic Neuroendocrine Tumors and Diabetes Mellitus in a Seer-Medicare Cohort
por: Thapi, Sahityasri, et al.
Publicado: (2020)

Real‐world experience of carfilzomib‐associated cardiovascular adverse events: SEER‐Medicare data set analysis
por: Bishnoi, Rohit, et al.
Publicado: (2020)

Risk factors for venous thromboembolism in metastatic colorectal cancer with contemporary treatment: A SEER‐Medicare analysis
por: Ades, Steven, et al.
Publicado: (2022)

Lack of survival advantage among re-resected elderly glioblastoma patients: a SEER-Medicare study
por: Goldman, Debra A, et al.
Publicado: (2020)

Disparities in cancer-specific and overall survival in black women with endometrial cancer: A Medicare-SEER study
por: Saris, Daniel H., et al.
Publicado: (2022)

Estimates of Overall Survival in Patients With Cancer Receiving Different Treatment Regimens: Emulating Hypothetical Target Trials in the Surveillance, Epidemiology, and End Results (SEER)–Medicare Linked Database
por: Petito, Lucia C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8rsmuour3cpjvul8c6r1f9j7o7